These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30591274)

  • 1. Papillomavirus vaccine for women, and for men?
    Hidalgo Tenorio C
    Med Clin (Barc); 2019 Apr; 152(7):264-265. PubMed ID: 30591274
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and prevention of Human Papillomavirus.
    Manini I; Montomoli E
    Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventing cancer: The role of Papillomavirus vaccination in the general population].
    Vié le Sage F; Cohen R
    Bull Cancer; 2020 Jan; 107(1):10-20. PubMed ID: 31982092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
    Luxembourg A; Moeller E
    Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against human papillomavirus.
    Mello CF
    Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
    Frazer IH
    Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 10. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 12. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical approval: Trials of an anticancer jab.
    Clayton J
    Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
    [No Abstract]   [Full Text] [Related]  

  • 16. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
    Stanley M; Dull P
    Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700
    [No Abstract]   [Full Text] [Related]  

  • 18. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Detection of Human Papillomavirus-Driven Oropharyngeal Cancer Using Serology From the Study of Prevention of Anal Cancer.
    Waterboer T; Brenner N; Gallagher R; Hillman RJ; Jin F; Grulich A; Poynten IM
    JAMA Oncol; 2020 Nov; 6(11):1806-1808. PubMed ID: 33001163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
    Soldan K; Dillner J
    Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.